One of the most promising areas of research. If we can replace our stem cells then they can replace our aging cells.
More info coming soon.
Direct-to-consumer stem cell marketing in CanadaFuture Medicine - 26-Sep-2018
30 Canadian businesses sell stem cell interventions at 43 clinics. Websites minimize risks while making strong claims about benefits. Fees not disclosed, but in region of CA$3-5,000. Autologous stem cells derived from adipose tissue, bone marrow and peripheral blood. No websites offered information concerning provision of long-term patient follow-up care.
Fujifilm to test stem cells in leukemia treatmentNikkei - 23-Sep-2018
Fujifilm's trial to target patients with acute graft-versus-host disease. Condition affects about 40% of bone marrow transplant recipients. Therapy uses induced pluripotent stem (iPS) cells. Hopes to win approval to manufacture and market the therapy in 2022. Aims to exploit experience of Australian venture Cynata Therapeutics. Cynata's UK clinical trials has 14 of 15 patients showing improvement. Plan to mass-produce mesenchymal stem cells made from iPS cells.
Wounds Healed With Reprogrammed Skin CellsSingularity Hub - 14-Sep-2018
Cutaneous ulcers can lead to serious infections or amputations. Typically treated by surgically transplanting existing skin to cover the wound. Isolating and growing skin stem cells from patient is time consuming. Salk Institute approach converts naturally present cells into new skin cells. Basal keratinocytes are precursors to many different types of skin cells. But large, severe wounds no longer have any basal keratinocytes. Newly generated cells functioned like healthy skin in mice.